MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
EDIT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Editas Medicine (EDIT) Ownership - Who owns Editas Medicine?

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
87
Web
https://www.editasmedicine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
427.39M
P/E Ratio
N/A
Total Cash
123.65M
Projected Growth
N/A
Total Debt
17.3M
Revenue
38.69M
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.42 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EDIT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for EDIT
A.I. Advisor
published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
87
Web
https://www.editasmedicine.com